1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU...

103
1 THE VACCINE-AUTISM THE VACCINE-AUTISM DEBATE: DEBATE: NEW NEW DEVELOPMENTS DEVELOPMENTS FROM SCIENCE AND POLICY FROM SCIENCE AND POLICY P P resentation by David Kirby resentation by David Kirby NYU Law School, New York City NYU Law School, New York City June 26th, 2008 June 26th, 2008

Transcript of 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU...

Page 1: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

1

THE VACCINE-AUTISMTHE VACCINE-AUTISM

DEBATE: DEBATE:

NEWNEW

DEVELOPMENTS DEVELOPMENTS

FROM SCIENCE AND FROM SCIENCE AND POLICY POLICY

PPresentation by David Kirbyresentation by David KirbyNYU Law School, New York CityNYU Law School, New York City

June 26th, 2008June 26th, 2008

Page 2: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

2

A NEW AUTISM VOCABULARYA NEW AUTISM VOCABULARYCause, Effect & Connections of:Cause, Effect & Connections of:

Immune Activation/Immune Immune Activation/Immune Suppression/AutoimmunitySuppression/Autoimmunity

Oxidative Stress/Reactive Oxidative Species (ROS)Oxidative Stress/Reactive Oxidative Species (ROS) Neuro-inflammation Neuro-inflammation Glutathione DepletionGlutathione Depletion Mitochondrial DysfunctionMitochondrial Dysfunction Impaired Oxidative PhosphorylationImpaired Oxidative Phosphorylation Metal Metabolism/Efflux Disorder Metal Metabolism/Efflux Disorder Activation of Astroglia & Microglia/“Gliosis”Activation of Astroglia & Microglia/“Gliosis” Cytokine Imbalance Cytokine Imbalance Methionine Cycle Disruption Methionine Cycle Disruption Impaired MethylationImpaired Methylation Impaired TransulfurationImpaired Transulfuration DemyelinationDemyelination

Page 3: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

3

Types and Causes of Types and Causes of “Autisms?”“Autisms?” Types?Types?

““Classic”Classic” “Regressive”“Regressive” ““Inborn” Inborn” “Environmental”“Environmental”

““Genetic” Genetic” “Acquired Neuro-Immune”“Acquired Neuro-Immune”““Neurodiverse”Neurodiverse” “Mitochondrial”“Mitochondrial”

Causes?Causes?Inherited Inherited nDNA*nDNA* mutations mutations MMR MMR (UK)(UK)Inherited Inherited mtDNA*mtDNA* mutations mutations Thimerosal Thimerosal (US)(US)““Spontaneous” mutationsSpontaneous” mutations Mercury etc. in air, food, water Mercury etc. in air, food, water ““Epigenetics”Epigenetics” Multi-vaccines: over-stimulation Multi-vaccines: over-stimulation ““Geeks get lucky”Geeks get lucky” Pesticides, chemicals, jet fuelPesticides, chemicals, jet fuel

Flame retardants, solvents Flame retardants, solvents Wireless phones, TV, sonogramsWireless phones, TV, sonograms

*known causes*known causes Thalidomide*, terbutaline,* Thalidomide*, terbutaline,* rubella* rubella*

Page 4: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

4

IS AUTISM ON IS AUTISM ON

THE THE RISERISE??

Page 5: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

5

AUTISM RATES IN THE USAUTISM RATES IN THE US

0

20

40

60

80

Cases Per10,000

3 20 40 60 66

1980s 1990s 2000 2005 2008

Page 6: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

6

AUTISM RATES IN THREEAUTISM RATES IN THREEEUROPEAN COUNTRIESEUROPEAN COUNTRIES

0

20

40

60

80

100

120

Rates per 10K 5 66 116 7.7 9.2 15.6

UK 1990

UK 2004

UK 2006

DK 2001

POR 2007

AZR 2007

US 2008

Page 7: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

7

Is There a “Hidden Is There a “Hidden Horde?”Horde?”

Reported autism in US – ca1988: 3 per 10,000Reported autism in US – ca1988: 3 per 10,000 Reported autism in US – ca2008: 66 per 10,000 (40 per Reported autism in US – ca2008: 66 per 10,000 (40 per

10,000 DSM-IV)10,000 DSM-IV)

Did doctors “miss” 63 out of 66 children with Did doctors “miss” 63 out of 66 children with autism, autism, or 95% of or 95% of allall ASD cases, until recent years? ASD cases, until recent years?

Even if 60% of ASD isEven if 60% of ASD is “full blown” “full blown” DSM-IV autism?DSM-IV autism?

0

10

20

30

40

50

60

70

1988 2008

Cases per 10k95%? 60%

DSM-IV

40% PDD-AS

DSM-IV

Page 8: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

8

“Autism and the Environment: Challenges & Opportunities for Research” - Pediatrics

2008;121;1225 April 2007, IOM Neuroscience workshop on

“most promising & urgent scientific questions.” “The environment may play a significant role in

triggering autism, probably through a complex interaction with genetic susceptibilities.”

“ “Evidence points to a large genetic component, Evidence points to a large genetic component, but but genes alone cannot accountgenes alone cannot account for its etiology.” for its etiology.”

Report praised involvement of Report praised involvement of parentsparents in the in the process.process.

Page 9: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

ARGUMENTS ARGUMENTS AGAINST AGAINST A VACCINE/A VACCINE/ MERCURY MERCURY

LINKLINK

Page 10: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

10

VSD: Generation VSD: Generation “0” “0” (FOIA)(FOIA)

Page 11: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

11

VSD: Generation VSD: Generation 44 Final Report Final Report

Vol. 112 No. 5 November Vol. 112 No. 5 November 2003,2003,

pp. 1039-1048pp. 1039-1048

                                                                  

                                                                  

                                                                  

                                                                  

“In no analyses were significant increased risks found for autismor attention-deficit disorder.”

Page 12: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

12

VSD Autism Risk Across 5 VSD Autism Risk Across 5 GenerationsGenerations1999-20031999-2003

0

2

4

6

8

Relative Risk 7.62 2.48 1.69 1.52 0

Gen 0 Gen 1 Gen 2 Gen 3 Gen 4

Page 13: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

13

THIMEROSAL EXPOSURE & AUTISM IN DENMARK Inpatient Only (13%)1981-1994

Inpatient & Outpatient (100%) 1994-2000

SOURCE: Stehr-Green, et al, AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 25, no. 2 (August 2003): 101-6

Page 14: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

14

DENMARK: Autism RatesDENMARK: Autism RatesDROPDROP in 2000 and 2001in 2000 and 2001

Page 15: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

15

2004 IOM Report: 2004 IOM Report: Preference Given to Preference Given to

EpidemiologyEpidemiology over over BiologyBiology Federal Courts:Federal Courts: “Epidemiology is not “Epidemiology is not

acceptable”acceptable” to disprove causation. to disprove causation.

2004 IOM Report2004 IOM Report: “We : “We cannot rule out,cannot rule out, based based on the epidemiology,on the epidemiology, the possibility that vaccines the possibility that vaccines contribute to autism in some small subset.” contribute to autism in some small subset.”

Danish authorsDanish authors: : epidemiological expansionepidemiological expansion of of criteria (inpatient-outpatient change) “may have criteria (inpatient-outpatient change) “may have spuriously increasedspuriously increased the apparent number of the apparent number of autism cases.”autism cases.”

VerstraetenVerstraeten: “We found no evidence against an : “We found no evidence against an association, as a negative study would. Additional association, as a negative study would. Additional study is recommended, which is the conclusion to study is recommended, which is the conclusion to which a which a neutral study neutral study must come.” must come.”

Page 16: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

16

2005 -2005 - IOM SPECIAL IOM SPECIAL REPORT REPORT

QUESTIONS CDC QUESTIONS CDC METHODSMETHODS IOM panel said CDC’s handling of VSD data IOM panel said CDC’s handling of VSD data

suffered from a suffered from a “lack of transparency.”“lack of transparency.” Original datasets were removed from hard Original datasets were removed from hard

drive, copied to disc, sent to Atlanta and lost.drive, copied to disc, sent to Atlanta and lost. Datasets “were not archived in a standard Datasets “were not archived in a standard

manner” & “are manner” & “are not available for reanalysisnot available for reanalysis.”.” IOM panel said CDC vaccine officials should IOM panel said CDC vaccine officials should

“seek legal advice”“seek legal advice” about Federal Data Quality about Federal Data Quality Act.Act.

Felony to lose or destroy taxpayer funded Felony to lose or destroy taxpayer funded records – Possible jail time for violators.records – Possible jail time for violators.

Page 17: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

17

20062006 - NIEHS PANEL - NIEHS PANEL QUESTIONS VSD FOR QUESTIONS VSD FOR

FUTURE USEFUTURE USE December 2006 - NIH panel “identified several serious December 2006 - NIH panel “identified several serious

problems” with VSD. Panel Report was signed by NIH problems” with VSD. Panel Report was signed by NIH Director.Director.

““Several weaknesses and limitations” would render a an Several weaknesses and limitations” would render a an ecological analysis "uninformative and potentially ecological analysis "uninformative and potentially misleading.”misleading.”

Concern over diagnoses recorded by HMO's, which likely Concern over diagnoses recorded by HMO's, which likely led to an "under-ascertainment" of cases. (CA rates were led to an "under-ascertainment" of cases. (CA rates were 3-4 per 1,000, but VSD reported just 1.1 per 1,000).3-4 per 1,000, but VSD reported just 1.1 per 1,000).

25% of births were excluded from the analysis. “A 25% of births were excluded from the analysis. “A susceptible population whose removal from the analysis susceptible population whose removal from the analysis might unintentionally reduce the ability to detect an might unintentionally reduce the ability to detect an effect of thimerosal.”effect of thimerosal.”

Page 18: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

18

2006 - NIEHS2006 - NIEHS: MORE PROBLEMS WITH VSD : MORE PROBLEMS WITH VSD

Other "serious problems” - No consideration of Other "serious problems” - No consideration of immune globulin (RhoGam) and flu shots during immune globulin (RhoGam) and flu shots during pregnancy. pregnancy.

No accounting for "cumulative exposure to organic No accounting for "cumulative exposure to organic mercurials through diet or other environmental mercurials through diet or other environmental sources.”sources.”

These problems "reduce the usefulness" to prove or These problems "reduce the usefulness" to prove or disprove a link to thimerosal going into the future - disprove a link to thimerosal going into the future - though they can be fixed.though they can be fixed.

““The VSD wasn't the last word. It was an improvement The VSD wasn't the last word. It was an improvement on other studies, including the two in Denmark, both on other studies, including the two in Denmark, both of which had serious weaknesses in their designs.”of which had serious weaknesses in their designs.”

Dr. Irva Hertz-Picciotto, Dr. Irva Hertz-Picciotto, NIH Panel Chair, NIH Panel Chair, Prof of Public Health, UC-Davis Prof of Public Health, UC-Davis Med SchoolMed School

Page 19: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

19

2008 – CDC Responds to NIEHS Critiques

Page 20: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

20

CDCCDC - Detailed Response to - Detailed Response to “Weaknesses”“Weaknesses”

Finding: ASD Diagnostic Criteria Too Narrow

Finding: Variations in Business Practices

Page 21: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

21

CDC:CDC: More Responses More ResponsesFINDING: No Accounting for Background Mercury

FINDING: Low Case Ascertainment

CDC: No studies were ecological: Chart reviews, neuro-psychological exams, and parent interviews were done (though not in Verstraeten)

Page 22: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

22

20062006 Cochrane Review: Cochrane Review: MMRMMR

Taylor 1999 - Taylor 1999 - “Demonstrates the difficulties of “Demonstrates the difficulties of drawing inferences in the drawing inferences in the absence of a non-exposed absence of a non-exposed populationpopulation or a clearly defined causal hypothesis.” or a clearly defined causal hypothesis.”

Fombonne 2001 - Fombonne 2001 - "The number and possible impact "The number and possible impact of biases was so high that of biases was so high that interpretation of the interpretation of the results is impossibleresults is impossible."."

Madsen 2002 - Madsen 2002 - ““Interpretation is made difficultInterpretation is made difficult by by the unequal length of follow up and use of date of the unequal length of follow up and use of date of diagnosis rather than onset of symptoms."diagnosis rather than onset of symptoms."

De Stefano 2004 – De Stefano 2004 – “Probable bias in enrollment; “Probable bias in enrollment; cases may cases may not be representativenot be representative of the rest of the of the rest of the population of the city."population of the city."

Smeeth 2004 – Smeeth 2004 – Only 4-13% unexposed controls - Only 4-13% unexposed controls - “Such a low number may indicate some “Such a low number may indicate some bias in the bias in the selection selection of controls."of controls."

Page 23: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

23

Other StudiesOther Studies (for Q&A) (for Q&A) MillerMiller – UK: Hg protects kids against neuro – UK: Hg protects kids against neuro

disorders; (some parents demand Hg in shots).disorders; (some parents demand Hg in shots). FombonneFombonne – Canada: PDD rates rise in – Canada: PDD rates rise in

Montreal after removal of Hg; (immigrant rate Montreal after removal of Hg; (immigrant rate is twice as high).is twice as high).

PichicheroPichichero – US/Argentina – Ethylmercury – US/Argentina – Ethylmercury clears from blood quickly (but not necessarily clears from blood quickly (but not necessarily from body)from body)

NEJMNEJM – No neuropsych effects from thimerosal – No neuropsych effects from thimerosal (except for a more than double risk for tics)(except for a more than double risk for tics)

CaliforniaCalifornia – Thimerosal came out but ASD still – Thimerosal came out but ASD still rising (Confounding factors?)rising (Confounding factors?)

Page 24: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

EVIDENCE TO EVIDENCE TO SUPPORTSUPPORT A THIMEROSAL-A THIMEROSAL-MERCURY LINK MERCURY LINK

Page 25: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

25

Mercury in US childhood vaccines Mercury in US childhood vaccines TRIPLED TRIPLED (75mcg to 237.5mcg) (75mcg to 237.5mcg)

from 1988-1992from 1988-1992

0

50

100

150

200

250

70s-80s

1988 ~1989 1992

3 DTP = 75mcg

4 HiB=175mcg

1 DTaP=200mcg

3 HepB=237.5

Page 26: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

26

Hg BURDEN AND AUTISM Hg BURDEN AND AUTISM RATES IN CALIFORNIA RATES IN CALIFORNIA

1985-981985-98

SOURCE: IOM Immunization Safety Report, 2001

Page 27: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

27

TYPICAL FLU SHOT INGREDIENT

25 micrograms Hg – EPA Limit: 0.1mcg/Kg/day 110 lb woman = 5 times over EPA daily limit – 14 lb infant = 17 times over limit

1.1 lb fetus = 50 times over EPA daily limit

Page 28: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

28

Chelation results from child Chelation results from child with ASDwith ASD

Page 29: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

29

THIOLSTHIOLS “MERCURY CAPTURERS”“MERCURY CAPTURERS”

ThiolThiol – A class of – A class of SULFUR-BASEDSULFUR-BASED proteins that proteins that bind with heavy metals and help eliminate bind with heavy metals and help eliminate them from the system.them from the system.

Thiols include – GlutaThiols include – Glutathiothione, cysteine, ne, cysteine, metallothioneine. Glutathione is also a metallothioneine. Glutathione is also a powerful antioxidant.powerful antioxidant.

Synonym for thiol - “mercaptan” from the Latin Synonym for thiol - “mercaptan” from the Latin mercurium captansmercurium captans: : “capturing mercury.”“capturing mercury.”

Chelation – Also sulfur-based; DMPS = Di-Chelation – Also sulfur-based; DMPS = Di-MercaptoMercapto-Succinic Acid-Succinic Acid

Page 30: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

30

ASD kids have low or depleted levels of “thiols,” ASD kids have low or depleted levels of “thiols,” including glutathione – a powerful antioxidant.including glutathione – a powerful antioxidant.

Low thiols levels are thought to be based on genes - and Low thiols levels are thought to be based on genes - and possible mercury exposure (See: R. Deth).possible mercury exposure (See: R. Deth).

Methionine “metabolites” (methionine, cysteine, Methionine “metabolites” (methionine, cysteine, glutathione) in 20 children with autism compared vs. glutathione) in 20 children with autism compared vs. controls revealed severely abnormal profiles.controls revealed severely abnormal profiles.

Targeted nutritional intervention with Folinic acid, and Targeted nutritional intervention with Folinic acid, and Betaine resulted in significant improvement in Betaine resulted in significant improvement in methylation capacity in children with autism.methylation capacity in children with autism.

Addition of methyl B-12 to “cocktail” brought all autistic Addition of methyl B-12 to “cocktail” brought all autistic children within normal levels of methionine, cysteine children within normal levels of methionine, cysteine and glutathione. and glutathione.

Page 31: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

31

METHYLATION: NEEDED FOR METHIONINE CYCLE AND TRANSULFURATION PATHWAY

Page 32: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

32

Thimerosal and Immune Cells – UC Davis Thimerosal and Immune Cells – UC Davis M.I.N.D. Institute – March 26/06M.I.N.D. Institute – March 26/06

Tiny amounts (nanomolars) of thimerosal Tiny amounts (nanomolars) of thimerosal can:can:

1) Kill immune (dendritic) cells1) Kill immune (dendritic) cells

2) Cause cytokine imbalances2) Cause cytokine imbalances

3) Induce inflammation.3) Induce inflammation.

THIMEROSAL CAN CAUSE THIMEROSAL CAN CAUSE IMMUNE IMBALANCESIMMUNE IMBALANCES

Page 33: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

33

AUTISM ASSOCIATED WITHAUTISM ASSOCIATED WITH IMMUNE IMBALANCES IMMUNE IMBALANCES

Presentation of UC Davis - MIND InstitutePresentation of UC Davis - MIND Institute2005 IMFAR - International Meeting for Autism Research 2005 IMFAR - International Meeting for Autism Research

Compared to typical children, those with ASD were found Compared to typical children, those with ASD were found to have:to have:

Increased autoimmunityIncreased autoimmunity

Extremely elevated levels of certain immune Extremely elevated levels of certain immune cells and cytokinescells and cytokines

Imbalances in the TH1/TH2 immune response Imbalances in the TH1/TH2 immune response

Page 34: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

34

Thomas Bubacher and team at Univ. of Washington Primate Center Thomas Bubacher and team at Univ. of Washington Primate Center compared ethylmercury from thimerosal and methylmercury from compared ethylmercury from thimerosal and methylmercury from fish. fish.

Methyl Hg stayed in blood longer, crossed blood-brain barrier more.Methyl Hg stayed in blood longer, crossed blood-brain barrier more.

BUT - Ethyl Hg in brain converts to inorganic Hg faster than methyl. BUT - Ethyl Hg in brain converts to inorganic Hg faster than methyl.

2-4 times more inorganic Hg found in brains of ethyl vs methyl 2-4 times more inorganic Hg found in brains of ethyl vs methyl group.group.

Over half the methyl-exposed brains had Over half the methyl-exposed brains had nono detectable inorganic Hg.detectable inorganic Hg.

Half-life in brain of organic Hg: 30 days; Half-life of inorganic: 20 Half-life in brain of organic Hg: 30 days; Half-life of inorganic: 20 yearsyears

Page 35: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

35

““Changes in Changes in astrocytesastrocytes and and microgliamicroglia in primate brains after long-term in primate brains after long-term methylmercury exposure.”methylmercury exposure.”

Burbacher: Inorganic Hg, presumably from Burbacher: Inorganic Hg, presumably from methyl Hg, continued to increase throughout all methyl Hg, continued to increase throughout all exposure durations.exposure durations.

Both Both astrocyte astrocyte andand microglial microglial cells had cells had “substantially elevated” inorganic mercury “substantially elevated” inorganic mercury deposits. deposits.

““Inorganic Hg in the brain may be a toxic form Inorganic Hg in the brain may be a toxic form responsible for responsible for activation activation ofof astrocyte astrocyte andand microglia.” microglia.”

Activation of Activation of astrocyte astrocyte andand microglial microglial cells was cells was not noted for six months or more, in some cases.not noted for six months or more, in some cases.

Neurotoxicology. 1996;17:127-138.

Page 36: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

36

JOHNS HOPKINS: ‘Neurological Activation

&Neuro-Inflammation in Brain of Autism Patients Annals of Neurology - Vol 57 No 1 January 2005

Inflammation found in autopsied autistic Inflammation found in autopsied autistic brains, produced bybrains, produced by ”activation of astroglia ”activation of astroglia and microglia.”and microglia.”

Inflammation apparently associated with Inflammation apparently associated with activation of the brain’s immune system.activation of the brain’s immune system.

Compared with controls, autistic tissue Compared with controls, autistic tissue showed ongoing inflammation in various showed ongoing inflammation in various sections of brain.sections of brain.

Page 37: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

37

HARVARD:HARVARD:“Large Brains in Autism: The “Large Brains in Autism: The

Challenge of Pervasive Challenge of Pervasive Abnormality” Abnormality”

The NeuroscientistThe Neuroscientist, Volume 11, Number 5, 2000, Volume 11, Number 5, 2000

Neuro-inflammation, oxidative Neuro-inflammation, oxidative stress & stress & microgliamicroglia damage found in damage found in autistic brain tissue. autistic brain tissue.

“Chronic disease or external “Chronic disease or external environmental sources” (ie, heavy environmental sources” (ie, heavy metals) may be the cause. metals) may be the cause.

““Oxidative stress, brain Oxidative stress, brain inflammation, and inflammation, and microgliosismicrogliosis has has been much documented in been much documented in association with heavy metal association with heavy metal exposures.”exposures.”

Page 38: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

38

““Blood Levels of Mercury Are Related toBlood Levels of Mercury Are Related to Diagnosis of Autism: Reanalysis of an Diagnosis of Autism: Reanalysis of an Important Data SetImportant Data Set

””Journal of Child NeurologyJournal of Child Neurology, Vol. 22, No. 11, 1308-1311 (2007), Vol. 22, No. 11, 1308-1311 (2007)

““We reanalyzed the data set reported by Ip We reanalyzed the data set reported by Ip et al. and found the original et al. and found the original pp value was in value was in error.”error.”

““A significant relation A significant relation does existdoes exist between between the blood levels of mercury and diagnosis the blood levels of mercury and diagnosis of an autism spectrum disorder.”of an autism spectrum disorder.”

““Hair samples offer some support for the Hair samples offer some support for the idea that persons with autism may be less idea that persons with autism may be less efficient and more variable at eliminating efficient and more variable at eliminating mercury from the blood.” mercury from the blood.”

Page 39: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

39

Study looked at Texas county levels of Study looked at Texas county levels of emissions, compared to ASD rates and special emissions, compared to ASD rates and special ed in 1,200 school districts. ed in 1,200 school districts.

Autism increased as mercury emissions rose. Autism increased as mercury emissions rose. For every thousand pounds of Hg, there was a For every thousand pounds of Hg, there was a 61 percent increase in autism rates.61 percent increase in autism rates.

One county with low mercury emissions but One county with low mercury emissions but significant autism rates was found to harbor significant autism rates was found to harbor one of the nation’s largest mercury mines. one of the nation’s largest mercury mines.

““A potentially important connection between A potentially important connection between environmental exposure to mercury and the environmental exposure to mercury and the development of autism.”development of autism.”

UNIV of TEXAS - 2005: “HIGHER RISK OF AUTISM NEAR COAL-FIRED PLANTS” - Health & Place - 12 (2006) 203-20912 (2006) 203-209

Page 40: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

40

ENVIRONMENTAL HEALTH PERSPECTIVESENVIRONMENTAL HEALTH PERSPECTIVES – – Vol. 114 No. 9, September, 2006Vol. 114 No. 9, September, 2006

Funded by CDC - 284 ASD children & 657 controls, Funded by CDC - 284 ASD children & 657 controls, born in 1994 in SF Bay Area. Assigned exposure born in 1994 in SF Bay Area. Assigned exposure level by birth tract for 19 chemicals.level by birth tract for 19 chemicals.

Risks for autism were elevated by 50% in tracts Risks for autism were elevated by 50% in tracts with the highest chlorinated solvents and heavy with the highest chlorinated solvents and heavy metals.metals.

Highest risk compounds were mercury, cadmium, Highest risk compounds were mercury, cadmium, nickel, trichloroethylene, and vinyl chloride. Risk nickel, trichloroethylene, and vinyl chloride. Risk from heavy metals was almost twice as high as from heavy metals was almost twice as high as solvents.solvents.

““Our results suggest a potential association Our results suggest a potential association between autism and estimated metal between autism and estimated metal concentrations, and possibly solvents, in ambient concentrations, and possibly solvents, in ambient air around the birth residence.” air around the birth residence.”

Page 41: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

41

Univ. Of TexasUniv. Of Texas – “Study links autism risk to – “Study links autism risk to distance from mercury-releasing sources” distance from mercury-releasing sources”

Health and Place – April 2008Health and Place – April 2008

Hg data from 39 coal plants and 56 industrial Hg data from 39 coal plants and 56 industrial facilities in Texas. ASD rates culled from facilities in Texas. ASD rates culled from 1,040 Texas school districts.1,040 Texas school districts.

For every 1,000 pounds of Hg, there was a For every 1,000 pounds of Hg, there was a

3.7% increase in ASD. Prevalence fell 1-2% 3.7% increase in ASD. Prevalence fell 1-2% every 10 miles from source. every 10 miles from source.

““11stst time in scientific literature that time in scientific literature that statistically significant statistically significant association between association between ASD risk and distanceASD risk and distance from Hg source was from Hg source was identified.”identified.”

““Not a definitive study, but just one more that Not a definitive study, but just one more that furthers the association.” Raymond Palmer.furthers the association.” Raymond Palmer.

Page 42: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

42

THE SHANGHAI PLUMETHE SHANGHAI PLUME(Moves up and down Pacific Coast)(Moves up and down Pacific Coast)

Lower urban mercury plume. 10-day traverse from South China Sea, ending May 5, 2002. Trajectory calculations by N.O.A.A.

Page 43: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

43

Page 44: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

44

Page 45: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

45

Annals of the School of Medicine, Universidad Nacional San Marcos,

Lima An Fac Med Lima 2007; 68(3)

“Neurotoxic Effects of Thimerosal, At Vaccine Doses, on the Encephalon and the Development

of Hamsters at 7 Days After Birth”

Thimerosal was associated with low body weight, low Thimerosal was associated with low body weight, low encephalon weight and smaller stature in hamsters. encephalon weight and smaller stature in hamsters.

Neurotoxic effects also produced in hippocampus, Neurotoxic effects also produced in hippocampus, cerebral cortex and cerebellum.cerebral cortex and cerebellum.

Decrease in neuronal density found in exposed group.Decrease in neuronal density found in exposed group. Neuronal necrosis, demyelination and gliosis also Neuronal necrosis, demyelination and gliosis also

found. found. Risk in thimerosal group was high and statistically Risk in thimerosal group was high and statistically

significant. significant.

Page 46: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

46

What About Al?What About Al?

Al – is a known neuro-Al – is a known neuro-toxintoxin Al – is Al – is synergisticsynergistic with Hg with Hg Al – is an immune Al – is an immune stimulantstimulant Al – is damaging to Al – is damaging to mitochondriamitochondria Al – is found in Al – is found in more shotsmore shots today, today,

maybe in higher concentrations, maybe in higher concentrations, (to offset Hg removal?)(to offset Hg removal?)

Al – is Al – is notnot your friend your friend

Page 47: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

THE HANNAH THE HANNAH POLINGPOLING CASECASE

Page 48: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

48

Poling Concession #1Poling Concession #1 November 9, 2007November 9, 2007

Hannah met all milestones in first 18 months. Hannah met all milestones in first 18 months.

At 9 monthsAt 9 months: Mimicking sounds, crawling, and : Mimicking sounds, crawling, and sitting.sitting.

At 12-monthAt 12-month pediatric visit: Saying “Mom” & pediatric visit: Saying “Mom” & “Dad,” pulling self up, cruising. “Dad,” pulling self up, cruising.

July 19, 2000 July 19, 2000 visitvisit - Hannah “spoke well” was - Hannah “spoke well” was “alert and active,” with regular bowel “alert and active,” with regular bowel movements and good sleeping habits.movements and good sleeping habits.

July 19, 2000July 19, 2000 visit – Hannah received 9 vaccines: visit – Hannah received 9 vaccines:

D-T-aP, M-M-R, Hib, Varivax, and PolioD-T-aP, M-M-R, Hib, Varivax, and Polio

Page 49: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

49

Poling Concession #1Poling Concession #1 July 21, 2000July 21, 2000 – Two days later: 102.3 degree fever, – Two days later: 102.3 degree fever,

“lethargic, irritable, and cried for long periods, with “lethargic, irritable, and cried for long periods, with intermittent, high-pitched screaming and a intermittent, high-pitched screaming and a decreased decreased response to stimuliresponse to stimuli.”.”

July 22–31, 2000July 22–31, 2000 - Behavior continued over next ten - Behavior continued over next ten days. Hannah also began to arch back when crying.days. Hannah also began to arch back when crying.

July 31, 2000July 31, 2000 – Hannah had 102 degree fever, – Hannah had 102 degree fever, diminished appetite, red dots on chest and “extremely diminished appetite, red dots on chest and “extremely irritable and inconsolable.”irritable and inconsolable.”

September 26, 2000September 26, 2000 - Hannah returned to hospital - Hannah returned to hospital with 102 degree fever, diarrhea, nasal discharge, with 102 degree fever, diarrhea, nasal discharge, reduced appetite, and reduced appetite, and pulling at her left earpulling at her left ear..

November 13, 2000November 13, 2000 – Hannah presented with more – Hannah presented with more diarrhea, vomiting, diminished energy, fever, and rash diarrhea, vomiting, diminished energy, fever, and rash on her cheek. on her cheek.

Page 50: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

50

Poling Concession #1Poling Concession #1 December 14, 2000December 14, 2000 - Doctor noted Hannah had - Doctor noted Hannah had

possible possible speech delayspeech delay, was , was less responsiveless responsive to to verbal direction since July, and verbal direction since July, and lost some lost some languagelanguage..

February 8, 2001February 8, 2001 – “Encephalopathy progressed – “Encephalopathy progressed to persistent loss of previously acquired to persistent loss of previously acquired language, language, eye contacteye contact, and , and relatednessrelatedness, , following vaccinations of July, 2000. Hannah following vaccinations of July, 2000. Hannah watched the fluorescent lights repeatedlywatched the fluorescent lights repeatedly during during the examination and would not make eye the examination and would not make eye contact.”contact.”

February 8, 2001February 8, 2001 - Hannah diagnosed with - Hannah diagnosed with “regressive encephalopathy with features “regressive encephalopathy with features consistent with an autistic spectrum disorder, consistent with an autistic spectrum disorder, following normal development.”following normal development.”

May 17, 2001May 17, 2001 – Lab results “strongly indicated – Lab results “strongly indicated an underlying mitochondrial disorder.”an underlying mitochondrial disorder.”

Page 51: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

51

Poling Concession #1Poling Concession #1

October 4, 2001October 4, 2001 – Hannah found with – Hannah found with lactate-to-pyruvate ratio of 28:1, often seen lactate-to-pyruvate ratio of 28:1, often seen in disorders of mitochondrial oxidative in disorders of mitochondrial oxidative phosphorylation. (Reference ratio is 20:1) phosphorylation. (Reference ratio is 20:1) Confirmed with muscle biopsy.Confirmed with muscle biopsy.

February 2004February 2004 - Mitochondrial DNA analysis - Mitochondrial DNA analysis revealed single nucleotide change in the 16S revealed single nucleotide change in the 16S ribosomal RNA gene (T2387C).ribosomal RNA gene (T2387C).

April 14, 2006April 14, 2006 - Hannah brought by - Hannah brought by ambulance to Athens Regional Hospital and ambulance to Athens Regional Hospital and developed tonic seizure. Diagnosed with developed tonic seizure. Diagnosed with complex partial seizure disorder. This complex partial seizure disorder. This epilepsy was NOT related to vaccinations.epilepsy was NOT related to vaccinations.

Page 52: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

52

Poling Concession #1 Poling Concession #1 ConclusionConclusion

Nov 9, 2007Nov 9, 2007

““Medical personnel at the Division of Vaccine Medical personnel at the Division of Vaccine Injury Compensation of HHS have conducted a Injury Compensation of HHS have conducted a thorough review and concluded that thorough review and concluded that compensation is appropriatecompensation is appropriate.”.”

“ “The vaccinations Hannah received The vaccinations Hannah received significantly significantly aggravatedaggravated an underlying an underlying mitochondrial disorder, which predisposed her mitochondrial disorder, which predisposed her to deficits in cellular energy metabolism, and to deficits in cellular energy metabolism, and manifested asmanifested as a regressive encephalopathy a regressive encephalopathy with with features of autismfeatures of autism spectrum disorder.” spectrum disorder.”

Page 53: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

53

Poling Concession #2Poling Concession #2February 21, 2008February 21, 2008

Amended report from Dr. Zimmerman:Amended report from Dr. Zimmerman:

““The The causecause for regressive encephalopathy at for regressive encephalopathy at age 19 months was underlying mitochondrial age 19 months was underlying mitochondrial dysfunctiondysfunction, exacerbated, exacerbated byby vaccine vaccine-induced -induced feverfever and and immune stimulationimmune stimulation that exceeded that exceeded metabolic reserves.” Epilepsy was “part of the metabolic reserves.” Epilepsy was “part of the same pathogenesis that led to same pathogenesis that led to autistic autistic encephalopathyencephalopathy.”.”

SHORT VERSION: Hannah’s autism was SHORT VERSION: Hannah’s autism was caused by a vaccine-induced exacerbation of caused by a vaccine-induced exacerbation of her underlying mitochondrial dysfunction.her underlying mitochondrial dysfunction.

Page 54: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

54

CNN Worldwide Coverage: CNN Worldwide Coverage: “Vaccine “Vaccine case draws new case draws new

attention to autism debate”attention to autism debate”

March 6th - March 6th - CNN - Live 30 Minute April 2nd - CNN “Larry CNN International Press Conference from Atlanta King Live” - and Interview Courthouse with Polings All Day Coverage

Page 55: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

55

CDC Director Gerberding CDC Director Gerberding Reacts:Reacts:

“Cause” or “Precipitator?”“Cause” or “Precipitator?”““The government has made absolutely no The government has made absolutely no statement about indicating that vaccines are a statement about indicating that vaccines are a causecause of autism. That is a complete of autism. That is a complete mischaracterization of the findings of the mischaracterization of the findings of the case.” – case.” – Conference Call, March 5Conference Call, March 5

““The court (government) apparently made the The court (government) apparently made the decision that it is fair to say that vaccinations decision that it is fair to say that vaccinations may have been one of the may have been one of the precipitatorsprecipitators.”.”

– – Press Conference, Press Conference, March 6March 6

Page 56: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

56

Dr. Gerberding on CNNDr. Gerberding on CNNMarch 29, 2008March 29, 2008

““If a child was immunized, got a fever, had If a child was immunized, got a fever, had other other complications from the vaccinescomplications from the vaccines, and , and (is) pre-disposed with the mitochondrial (is) pre-disposed with the mitochondrial disorder, it can certainly set off some disorder, it can certainly set off some damage.” damage.”

““Some of these symptoms can be symptoms Some of these symptoms can be symptoms that have characteristics of that have characteristics of autismautism." ."

““I think we have to have an I think we have to have an open mindopen mind about this.”about this.”

Page 57: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

57

CDC Multiple Vaccine CDC Multiple Vaccine Q&AQ&ASource: Source: www.cdc.govwww.cdc.gov

Q: Is simultaneous vaccination with multiple vaccines Q: Is simultaneous vaccination with multiple vaccines safe? Wouldn't it be safer to separate combination safe? Wouldn't it be safer to separate combination vaccines?vaccines?

A: “The A: “The availableavailable scientific data show that simultaneous scientific data show that simultaneous vaccination with multiple vaccines has no adverse effect on vaccination with multiple vaccines has no adverse effect on the the normalnormal childhood immune system.” childhood immune system.”

Q: Can so many vaccines, given so early in life, Q: Can so many vaccines, given so early in life, overwhelm a child's immune system, suppressing it so overwhelm a child's immune system, suppressing it so it does not function correctly?it does not function correctly?

A: “No evidence suggests that the recommended childhood A: “No evidence suggests that the recommended childhood vaccines can ‘overload’ the immune system. Babies are vaccines can ‘overload’ the immune system. Babies are exposed to numerous bacteria and viruses on a daily basis.”exposed to numerous bacteria and viruses on a daily basis.”

Q: But are they injected with stimulants like aluminum, Q: But are they injected with stimulants like aluminum, Hg etc?Hg etc?

Page 58: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

58

““Commentary: A view from Commentary: A view from the CDC”the CDC”

CNN - April 3, 2008CNN - April 3, 2008

““Some may call it a ‘one size fits all’ Some may call it a ‘one size fits all’ approach, but the recommended approach, but the recommended vaccine schedule is vaccine schedule is flexibleflexible… parents … parents shouldn't be reluctant to have such shouldn't be reluctant to have such discussions with the child’s doctor.”discussions with the child’s doctor.”

““We're currently conducting the We're currently conducting the largest study to investigate the largest study to investigate the potential causes of autism, looking potential causes of autism, looking at genetic, environmental and at genetic, environmental and hormonal factors, as well as selected hormonal factors, as well as selected mercury exposuresmercury exposures.” .”

Page 59: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

MITOCHONDRIALMITOCHONDRIAL DYSFUNCTION AND DYSFUNCTION AND ASD REGRESSIONASD REGRESSION

Page 60: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

60

““Mighty Mito” Mighty Mito” FactsFacts

MITO - MITO - “disease”“disease” in classic form is very rare: 2- in classic form is very rare: 2-per-10K (0.02%) in general population. per-10K (0.02%) in general population.

MITO - MITO - “dysfunction”“dysfunction” in ASD is more prevalent. in ASD is more prevalent. Some studies show 10%-20 %, maybe more Some studies show 10%-20 %, maybe more among regressive cases: among regressive cases: 1000 times more 1000 times more common?common?

MITO - dysfunction can be very mild - many are MITO - dysfunction can be very mild - many are unaware. Severe forms usually inherited, can be unaware. Severe forms usually inherited, can be fatal in youth.fatal in youth.

MITO - disease 1MITO - disease 1stst noted in 1940s: Same decade noted in 1940s: Same decade as autism.as autism.

MITO - dysfunction can cause weak muscle tone, MITO - dysfunction can cause weak muscle tone, fatigue, poor digestion, other ASD signs. Mito fatigue, poor digestion, other ASD signs. Mito treatments used in ASDtreatments used in ASD..

Page 61: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

61

Three Sources of Mito Three Sources of Mito DisordersDisorders

SourcesSources: Cleveland Clinic and UMDF: Cleveland Clinic and UMDF

1) Inherited from mother (in Mito DNA)1) Inherited from mother (in Mito DNA)

2) Inherited from both parents (in nuclear DNA)2) Inherited from both parents (in nuclear DNA)

3) “Sporadic” (acquired via medicines and 3) “Sporadic” (acquired via medicines and toxins).toxins).

““Sporadic” type estimated for 75% of all cases. Sporadic” type estimated for 75% of all cases.

Mitochondria can be damaged by mercury, Mitochondria can be damaged by mercury, aluminum, pesticides, formaldehyde, alcohol, aluminum, pesticides, formaldehyde, alcohol, even HIV meds like AZT (which delete large even HIV meds like AZT (which delete large segments of MtDNA).segments of MtDNA).

Page 62: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

62

““Developmental regression and Developmental regression and mitochondrial mitochondrial

dysfunction in a child with autism”dysfunction in a child with autism”Journal of Child Neurology.Journal of Child Neurology. 2006 Feb;21(2):170-2 2006 Feb;21(2):170-2

Poling, Frye, Shoffner, Zimmerman - Johns Hopkins Hospital, Poling, Frye, Shoffner, Zimmerman - Johns Hopkins Hospital, Baltimore, MDBaltimore, MD

Described “oxidative phosphorylation disorder” in 19-Described “oxidative phosphorylation disorder” in 19-month-old. Subtle abnormalities in some enzymes and month-old. Subtle abnormalities in some enzymes and amino acids.amino acids.

Authors looked at records of 159 patients with autism Authors looked at records of 159 patients with autism (DSM-IV) and 94 controls with other neurologic (DSM-IV) and 94 controls with other neurologic disorders.disorders.

Aspartate aminotransferase was elevated in 38% of Aspartate aminotransferase was elevated in 38% of

patients with autism compared with 15% of controls.patients with autism compared with 15% of controls. Serum creatine kinase level also was abnormally Serum creatine kinase level also was abnormally

elevated in 22 of 47 patients (47%) with autism. elevated in 22 of 47 patients (47%) with autism.

““Metabolic evaluation is indicated in autistic patients Metabolic evaluation is indicated in autistic patients and defects of oxidative phosphorylation might be and defects of oxidative phosphorylation might be prevalent."prevalent."

Page 63: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

63

““Evidence of Mitochondrial Evidence of Mitochondrial Dysfunction in Autism”Dysfunction in Autism”

American Journal of Biochemistry and BiotechnologyAmerican Journal of Biochemistry and Biotechnology 4 (2): 4 (2): 208-217, 2008208-217, 2008

““Many cases of autism show evidence of Many cases of autism show evidence of mitochondrial dysfunction (MtD) mitochondrial dysfunction (MtD) withoutwithout classic features associated with mitochondrial classic features associated with mitochondrial disease.”disease.”

““MtD appears to be more common in autism MtD appears to be more common in autism

and presents with less severe signs and and presents with less severe signs and symptoms.”symptoms.”

““Exposure to environmental toxins is the likely Exposure to environmental toxins is the likely etiology for mitochondrial dysfunction in etiology for mitochondrial dysfunction in autism.” autism.”

““This dysfunction then contributes to a number This dysfunction then contributes to a number of diagnostic symptoms observed in autism.”of diagnostic symptoms observed in autism.”

Page 64: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

64

““Heavy-Metal Toxicity: Emphasis on Heavy-Metal Toxicity: Emphasis on Mercury”Mercury”

Integrative Medicine Integrative Medicine • Vol. 6, No. 2 • Apr/May • Vol. 6, No. 2 • Apr/May 20072007

Neustadt MD & Pieczenik MDNeustadt MD & Pieczenik MD

““Metal toxicity creates multi-Metal toxicity creates multi-system dysfunction, which system dysfunction, which appears to be mediated primarily appears to be mediated primarily through through mitochondrial damagemitochondrial damage from from glutathione depletionglutathione depletion.”.”

Page 65: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

65

Estimates of Mito Dysfunction Estimates of Mito Dysfunction inin ASDASD

11) ) Oliveiro et al:Oliveiro et al: Markers for Mito dysfunction found Markers for Mito dysfunction found in 20% of ASD patients, and muscle biopsy confirmed in 20% of ASD patients, and muscle biopsy confirmed in in 7.2%.7.2%.

2) 2) Kelley, Zimmerman, Natowicz:Kelley, Zimmerman, Natowicz: Mitochondrial Mitochondrial dysfunction may account for dysfunction may account for 20%20% of ASD, especially of ASD, especially PDD-NOS with language and cognitive regression in PDD-NOS with language and cognitive regression in 22ndnd year. Markers on paternal lines; early testing, “may year. Markers on paternal lines; early testing, “may rescue some from more severe brain injury and rescue some from more severe brain injury and lifelong disability.” lifelong disability.”

3) 3) David HoltzmanDavid Holtzman, Massachusetts General Hospital, , Massachusetts General Hospital, AS Grant: “Oxidative Phosphorylation in Cells from AS Grant: “Oxidative Phosphorylation in Cells from Autistic Individuals.” Mito dysfunction might be found Autistic Individuals.” Mito dysfunction might be found in up to in up to 30%30% of ASD cases. of ASD cases.

4) 4) Petitioners Steering CommitteePetitioners Steering Committee – VICP – Up to – VICP – Up to 50%50% of 5,000 cases filed in Vaccine Court show markers for of 5,000 cases filed in Vaccine Court show markers for mild dysfunction.mild dysfunction.

Page 66: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

66

Some Markers for Some Markers for Mito Mito DysfunctionDysfunction

And Reported Rates in ASD And Reported Rates in ASD KidsKids

47% (elevated serum creatine kinase, Poling et 47% (elevated serum creatine kinase, Poling et al) al)

38% (elevated aspartate aminotransferase, 38% (elevated aspartate aminotransferase, Poling)Poling)

28% (elevated lactate/pyruvate ratio, (Correia et 28% (elevated lactate/pyruvate ratio, (Correia et al)al)

20% (elevated plasma lactate, Oliveiro et al)20% (elevated plasma lactate, Oliveiro et al) 17% (elevate plasma lactate, Correia et al)17% (elevate plasma lactate, Correia et al) 13-16% (two hyperlactidemia markers, Oliveiro 13-16% (two hyperlactidemia markers, Oliveiro

et al)et al) 65% - Shoffner (certain biomarkers)65% - Shoffner (certain biomarkers)

Page 67: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

67

Thimerosal Targets Thimerosal Targets MitochondriaMitochondria

““ThimerosalThimerosal induces neuronal cell apoptosis by causing induces neuronal cell apoptosis by causing cytochrome c and apoptosis-inducing factor release from cytochrome c and apoptosis-inducing factor release from mitochondriamitochondria.” .”

-- Intl Journal of Molecular Medicine. 2005 Dec;16(6):971-7. Intl Journal of Molecular Medicine. 2005 Dec;16(6):971-7.

““MitochondrialMitochondrial mediated mediated thimerosalthimerosal-induced apoptosis in a -induced apoptosis in a human neuroblastoma cell line”human neuroblastoma cell line”

-- Neurotoxicology. 2005 Jun;26(3):407-16. Neurotoxicology. 2005 Jun;26(3):407-16.

““Biochemical and molecular basis of Biochemical and molecular basis of thimerosalthimerosal-induced -induced apoptosis in T cells: a major role of apoptosis in T cells: a major role of mitochondrialmitochondrial pathway” pathway”

- - Genes & Immunology. 2002 Aug;3(5):270-8.Genes & Immunology. 2002 Aug;3(5):270-8.

““Inhibition of malate transport and activation of phosphate Inhibition of malate transport and activation of phosphate transport in transport in mitochondria mitochondria by by thimerosalthimerosal” - ” - FEBS Lett. 1980 FEBS Lett. 1980 Aug 11;117(1):149-51.Aug 11;117(1):149-51.

““MercurialMercurial-induced hydrogen peroxide generation in mouse -induced hydrogen peroxide generation in mouse brain brain mitochondriamitochondria” - ” - Chem Res Toxicol. 2007 Chem Res Toxicol. 2007 Dec;20(12):1919-26.Dec;20(12):1919-26.

Page 68: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

68

“Bridging from Cells to Cognition in Autism: Pathways to Defective Brain

Function and Plasticity”Dr. Martha Herbert, Harvard – Am. Journ. Biochem. & Biotech

4 (2): 167-176, 2008

Autism may begin when an early environmental, infectious, seizure, or autoimmune insult triggers an immune response.

This response increases oxidative stress in the brain.

Oxidative stress leads to DNA damage (nuclear and mitochondrial) and metabolic (glutathione) enzyme blockage.

Inflammatory and oxidative stressors persist beyond early development, producing ongoing functional consequences.

Page 69: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

69

“Bridging from Cells to Cognition in Autism: Pathways to Defective Brain

Function and Plasticity”

In the central nervous system, continued use of damaged mitochondria and impaired metabolic function may generate additional oxidative stress.

This oxidative stress causes further activation of the immune system, leading to even more oxidative stress.

Such a mechanism would self-sustain and possibly progressively worsen.

Mitochondrial dysfunction found in autism would activate both astroglia and microglia. These activated cells can then initiate a broad-spectrum pro-inflammatory gene response.

Page 70: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

70

Formaldehyde Causes Mito Damage, Formaldehyde Causes Mito Damage, Oxidative Stress and Glutathione Oxidative Stress and Glutathione

Depletion Depletion Chem Biol InteractChem Biol Interact. 2001 Jan 30;130-132(1-3):285-96. . 2001 Jan 30;130-132(1-3):285-96.

Low dose formaldehyde caused “marked Low dose formaldehyde caused “marked decrease in decrease in mitochondrialmitochondrial potential and inhibition of mitochondrial potential and inhibition of mitochondrial respiration,” as well as respiration,” as well as oxidative stressoxidative stress in cells. in cells.

GlutathioneGlutathione was also depleted in a dose-dependent was also depleted in a dose-dependent manner. manner.

““Antioxidants & iron Antioxidants & iron chelatorschelators protected against cell protected against cell toxicity.” toxicity.”

““Toxicity was prevented with cyclosporine orToxicity was prevented with cyclosporine or carnitine carnitine to to prevent opening ofprevent opening of mitochondrial mitochondrial permeability pore. permeability pore.

““This suggests formaldehyde targets This suggests formaldehyde targets mitochondriamitochondria.” .”

(NOTE: CDC repressed evidence of formaldehyde off-(NOTE: CDC repressed evidence of formaldehyde off-gassing in gassing in Hurricane KatrinaHurricane Katrina refugee trailers!) refugee trailers!)

Page 71: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

71

““Maternal Residence Near Agricultural Maternal Residence Near Agricultural Pesticide Applications & ASD in Pesticide Applications & ASD in

California’s Central Valley”California’s Central Valley”Environmental Health PerspectivesEnvironmental Health Perspectives

Volume 115, Number 10, October 2007 Volume 115, Number 10, October 2007 Calif. women living near farms with organo-Calif. women living near farms with organo-

chlorine pesticides may be more at risk for chlorine pesticides may be more at risk for children with autism.children with autism.

Autism rates near fields was extremely high - Autism rates near fields was extremely high - 28% of mothers had children with autism, six 28% of mothers had children with autism, six times higher than those who did not live nearby.times higher than those who did not live nearby.

7% of ASD in Central Valley might have been 7% of ASD in Central Valley might have been connected to insecticides from fields. connected to insecticides from fields.

Italian scientists in 2005: Pesticides “could Italian scientists in 2005: Pesticides “could cause neurological changes that lead to cause neurological changes that lead to autism.”autism.”

Page 72: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

ASD & PET SHAMPOO PESTICIDE?ASD & PET SHAMPOO PESTICIDE?IMFAR Meeting – IMFAR Meeting – London – May, 2008London – May, 2008

■ ■ Chemicals included insecticides, pet Chemicals included insecticides, pet shampoos, and weed killers, 3 months before shampoos, and weed killers, 3 months before conception until first birthday.conception until first birthday. ■ ■ Mothers of ASD kids were twice as likely Mothers of ASD kids were twice as likely to report using pet shampoos with pyrethrins to report using pet shampoos with pyrethrins vs. controls. Used for flea control, pyrethrins vs. controls. Used for flea control, pyrethrins affect pests' central nervous system. affect pests' central nervous system. ■ ■ Strongest association was in Strongest association was in secondsecond trimester, when ASD mothers were 2.6 times trimester, when ASD mothers were 2.6 times more likely to have been exposed to the more likely to have been exposed to the chemical. chemical.

■ ■ In lab, pyrethrins have also been found to In lab, pyrethrins have also been found to affect a part of the brain that protects it from affect a part of the brain that protects it from chemicals within the blood. chemicals within the blood.

Page 73: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

RECENT RECENT DEVELOPMENTS IN U.S. DEVELOPMENTS IN U.S. POLICY AND POLICY AND POLITICSPOLITICS

Page 74: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

74

The The NEXTNEXT Hannah Poling Hannah Poling

Case chosen to replace Hannah as 1Case chosen to replace Hannah as 1stst thimerosal test case had SAME mito thimerosal test case had SAME mito markers, and was also pulled as test markers, and was also pulled as test case.case.

This case will be re-filed outside of This case will be re-filed outside of Autism Omnibus Proceedings with Autism Omnibus Proceedings with new theory of causation: Autism can new theory of causation: Autism can be caused by aggravated be caused by aggravated mitochondrial dysfunction.mitochondrial dysfunction.

Page 75: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

75

Email from Email from HHSHHS to to CBS CBS

Here are the numbers of compensable cases for Here are the numbers of compensable cases for encephalitis / encephalopathy and seizures in our encephalitis / encephalopathy and seizures in our database from October 1, 1988 to March 4, 2008. database from October 1, 1988 to March 4, 2008.

Encephalitis/Encephalopathy 611Encephalitis/Encephalopathy 611 Seizure Disorders 711Seizure Disorders 711 Total 1,322Total 1,322

There's not much difference in the medical history There's not much difference in the medical history and outcomes for children that were compensated and outcomes for children that were compensated for "encephalopathy" versus "seizures." for "encephalopathy" versus "seizures."

Those compensated for encephalopathy often had Those compensated for encephalopathy often had seizures as part of their clinical picture, and vice seizures as part of their clinical picture, and vice versa. versa.

Page 76: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

76

2008 - CDC Studies on 2008 - CDC Studies on MMRMMR

www.cdc.gov/ncbddd/autism/documents/vaccine_stwww.cdc.gov/ncbddd/autism/documents/vaccine_studies.pdfudies.pdf

““The Autism and Biopsy Study” The Autism and Biopsy Study” Can MMR cause autism through persistent Can MMR cause autism through persistent measles infection in the intestine? Examination measles infection in the intestine? Examination of intestinal tissue of children with autism for the of intestinal tissue of children with autism for the presence of measles virus. presence of measles virus.

““Immunizations & Possible Immunizations & Possible Developmental Regression” Developmental Regression” CDC & NIH study of whether the MMR vaccine CDC & NIH study of whether the MMR vaccine is linked with developmental regression, which is linked with developmental regression, which occurs in a subset of children with autism. occurs in a subset of children with autism.

Page 77: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

77

March 11 -March 11 - CDC Conference CDC Conference Call on Mito Dysfunction, Call on Mito Dysfunction,

Vaccines and AutismVaccines and Autism CISA - CDC, vaccine experts and insurance CISA - CDC, vaccine experts and insurance

companies – discussed 5-year study of 30 ASD kids companies – discussed 5-year study of 30 ASD kids w/low cellular energy.w/low cellular energy.

All 30 had the All 30 had the samesame abnormalities as Hannah abnormalities as Hannah Poling, (who was one of them). All regressed after Poling, (who was one of them). All regressed after normal development.normal development.

Big surprise: “Inheritance pattern" found – When 2 Big surprise: “Inheritance pattern" found – When 2 two cousins had autism, genetic link was always two cousins had autism, genetic link was always through father – clear nuclear DNA inheritance.through father – clear nuclear DNA inheritance.

DNA mutation may range from 1-in-400 to DNA mutation may range from 1-in-400 to 1-in-501-in-50, , or 2%.or 2%.

DNA mapping underaway – paternal grandparents DNA mapping underaway – paternal grandparents tested.tested.

Page 78: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

78

CDC-CISA Conference Call – CDC-CISA Conference Call – Cont’dCont’d

BUT – is DNA mutation enough to confer MtD? BUT – is DNA mutation enough to confer MtD? Or is an environmental trigger needed? And what Or is an environmental trigger needed? And what triggers "metabolic decomposition" anyway?triggers "metabolic decomposition" anyway?

In only 2 of the 30 cases, (6%) regression linked In only 2 of the 30 cases, (6%) regression linked to shots (Hannha was one).to shots (Hannha was one).

In other 28 cases, traced to fever-inducing In other 28 cases, traced to fever-inducing infection.infection.

But if fever causes 94% of mito reggression, But if fever causes 94% of mito reggression,

shouldn’t there be less today - and less in shouldn’t there be less today - and less in wealthier countries? wealthier countries?

(Hannah spoke at 9 months, but had several (Hannah spoke at 9 months, but had several fevers after that without regression. Now, fevers fevers after that without regression. Now, fevers improve symptoms - reported in Pediatrics).improve symptoms - reported in Pediatrics).

Page 79: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

79

““Three-Step, Two-Trigger” Path Three-Step, Two-Trigger” Path STEP ONESTEP ONE: Child is born with DNA mutation for : Child is born with DNA mutation for

mito susceptibility.mito susceptibility.

TRIGGER ONE:TRIGGER ONE: Child encounters pre- or neo-natal Child encounters pre- or neo-natal environmental trigger.environmental trigger.

STEP TWO:STEP TWO: Child develops mild, asymptomatic Child develops mild, asymptomatic mito dysfunction.mito dysfunction.

TRIGGER TWOTRIGGER TWO: Fever and/or immune : Fever and/or immune overstimulation from infection of vaccines overstimulation from infection of vaccines “exceeds metabolic reserves.”“exceeds metabolic reserves.”

STEP THREE:STEP THREE: Encephalopathy, illness, regression, Encephalopathy, illness, regression, autismautism

Page 80: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

80

Questions Raised On and Questions Raised On and From From

CDC – CISACDC – CISA Confernce Call Confernce Call Do we vaccinate children with known MtD sooner? Do we vaccinate children with known MtD sooner?

More slowly?More slowly? Do we develop an efficient test for MtD Do we develop an efficient test for MtD beforebefore

vaccination begins?vaccination begins?

Do we alter schedule somehow, to lower risk of Do we alter schedule somehow, to lower risk of immune over-stimulation in susceptible children?immune over-stimulation in susceptible children?

Do we set a maximum number of vaccine exposures on Do we set a maximum number of vaccine exposures on any one day?any one day?

Do we allow MMR to be separated out, on request of Do we allow MMR to be separated out, on request of parents?parents?

Do we separate MMR from Varicella on same day? Do we separate MMR from Varicella on same day? CDC stoped recommending Pro-Quad (MMR+V) CDC stoped recommending Pro-Quad (MMR+V) because it because it doubleddoubled seizure risk. seizure risk.

Do we set new limits on kids playing “catch up?”Do we set new limits on kids playing “catch up?”

Page 81: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

81

April 11, 2008April 11, 2008 – Meeting to – Meeting to Discuss Top Vaccine Safety Discuss Top Vaccine Safety

Issues in DCIssues in DCHHS convened first meeting of the national HHS convened first meeting of the national Vaccine Vaccine Safety Working GroupSafety Working Group to review CDC's to review CDC's recommended safety research agenda. recommended safety research agenda. SOME SOME Specific Questions:Specific Questions:

““Is thimerosal associated with risk for tics Is thimerosal associated with risk for tics and/or Tourettes?and/or Tourettes?

““Is acellular pertussis vaccine associated with Is acellular pertussis vaccine associated with risk for acute neurological events?”risk for acute neurological events?”

““Is combo MMRV vaccine associated with Is combo MMRV vaccine associated with increased febrile seizure risk?”increased febrile seizure risk?”

““Are varicella and MMRV vaccines associated Are varicella and MMRV vaccines associated with increased risk for clinically important with increased risk for clinically important events related to virus reactivation?”events related to virus reactivation?”

Page 82: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

82

CDC:CDC: Clinical Outcomes To Clinical Outcomes To StudyStudy

Autoimmune diseases Autoimmune diseases

Nervous system demyelinating Nervous system demyelinating disordersdisorders

Encephalitis/encephalopathyEncephalitis/encephalopathy

Neurodevelopmental disorders, Neurodevelopmental disorders, including autism spectrum disorder including autism spectrum disorder (ASD)(ASD)

Clinically important outcomes Clinically important outcomes associated with post-immunization associated with post-immunization fever.fever.

Page 83: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

83

CDC Also Proposes CDC Also Proposes Mito Mito Research:Research:

Q: “Is immunization associated Q: “Is immunization associated with increased risk for neurological with increased risk for neurological deterioration in children with deterioration in children with mitochondrial dysfunction?”mitochondrial dysfunction?”

““CISA has formed a working group CISA has formed a working group to study methods related to to study methods related to mitochondrial disorders and mitochondrial disorders and immunization, in collaboration with immunization, in collaboration with partners.”partners.”

Page 84: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

84

Workshop – Workshop – “Mitochondrial Disorders of Childhood: “Mitochondrial Disorders of Childhood: Testing, Potential Relationships to Autism Spectrum Testing, Potential Relationships to Autism Spectrum

Disorders, and Triggers for Neurological Deterioration”Disorders, and Triggers for Neurological Deterioration”June 29, 2008 – IndianapolisJune 29, 2008 – Indianapolis

Sponsored by HHS, CDC, FDA, NIH agencies; and timed around Sponsored by HHS, CDC, FDA, NIH agencies; and timed around United Mitochondrial Disease Foundation Meeting.United Mitochondrial Disease Foundation Meeting.

HHS: “Goals and Objectives - Convene 11 experts in HHS: “Goals and Objectives - Convene 11 experts in mitochondrial disorders or autism to discuss how the mitochondrial disorders or autism to discuss how the neurology of mitochondrial disorders might inform autism neurology of mitochondrial disorders might inform autism research.”research.”

UMDF: “Address neurological features of mitochondrial UMDF: “Address neurological features of mitochondrial

disorders, disorders, exacerbating factorsexacerbating factors, and testing and diagnosis.”, and testing and diagnosis.”

Page 85: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

85

6/19/086/19/08 -Should I vaccinate my -Should I vaccinate my baby?baby?

1. Delaying the first hepatitis B 1. Delaying the first hepatitis B shotshot

2. Not doing some shots at all2. Not doing some shots at all 3. Checking for 'titers' before 3. Checking for 'titers' before

giving booster shotsgiving booster shots 4. Spreading the vaccines out 4. Spreading the vaccines out

over a longer period of timeover a longer period of time 5. Splitting up combined shots5. Splitting up combined shots

                       /health

Page 86: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

86

Hillary Clinton on Autism:Hillary Clinton on Autism:Campaign QuestionnaireCampaign Questionnaire

Feb. 2008Feb. 2008

““Yes, (autism is Yes, (autism is epidemicepidemic). ). I am I am committed to make committed to make investmentsinvestments to to find the causes of autism, find the causes of autism, including possible environmental including possible environmental causes like causes like vaccinesvaccines.”.”

Page 87: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

87

Barack Obama on Autism:Barack Obama on Autism:Campaign Trail, Campaign Trail, Pennsylvania Pennsylvania

April, 2008April, 2008

““We've seen just a We've seen just a skyrocketingskyrocketing autism rate. Some people are autism rate. Some people are suspicious that it's connected to suspicious that it's connected to the the vaccinesvaccines. The science right now . The science right now is inconclusive, but we have to is inconclusive, but we have to researchresearch it.” it.”

Page 88: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

88

John McCain on Autism:John McCain on Autism:Campaign Trail, Texas Campaign Trail, Texas

March, 2008March, 2008

““It's indisputable that autism is It's indisputable that autism is on theon the riserise amongst children, the amongst children, the question is what's causing it. And question is what's causing it. And we go back and forth, and there's we go back and forth, and there's strong strong evidenceevidence that indicates that indicates that it's got to do with a that it's got to do with a preservative in preservative in vaccinesvaccines.”.”

Page 89: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

89

Dr. Bernadine Healy on Dr. Bernadine Healy on CBS NewsCBS NewsMay, 2008May, 2008

““Officials have been too quick to Officials have been too quick to dismiss the hypothesis as 'irrational,' dismiss the hypothesis as 'irrational,' without sufficient studies of without sufficient studies of causation, causation, without studying the without studying the population that got sick.”population that got sick.”

““Never turn your back on any Never turn your back on any scientific hypothesis because you are scientific hypothesis because you are afraid of what it might show." afraid of what it might show."

Page 90: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

90

Healy on CBS NewsHealy on CBS News

The IOM concluded there is no link The IOM concluded there is no link based mostly on population studies. based mostly on population studies. But, But, “Populations do not test “Populations do not test causalitycausality they test associations.” they test associations.”

““I am a member of the IOM. I love the I am a member of the IOM. I love the IOM. But a report from 2004 basically IOM. But a report from 2004 basically said, 'Don’t pursue susceptibility said, 'Don’t pursue susceptibility groups. Don't look for those children groups. Don't look for those children who may be vulnerable.' I really take who may be vulnerable.' I really take issue with that conclusion."issue with that conclusion."

Page 91: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

91

Dr. Healy on Don Imus Dr. Healy on Don Imus Radio ShowRadio ShowMay, 2008May, 2008

““The issue is really almost one of The issue is really almost one of ideology or religionideology or religion, more than it , more than it is of science. It is the sense that is of science. It is the sense that vaccines are critically vaccines are critically important.” important.”

Page 92: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

92

THE END: Remember the THE END: Remember the kidskids!!

Page 93: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

93

6/19/086/19/08 -Should I vaccinate -Should I vaccinate my baby?my baby?

Story HighlightsStory Highlights

Parents have concerns about possible Parents have concerns about possible vaccine and autism linkvaccine and autism link

Doctors from CDC say vaccine schedule Doctors from CDC say vaccine schedule is flexibleis flexible

Sears Schedule recommends spreading Sears Schedule recommends spreading vaccines out over timevaccines out over time

Looking at family history can give clues Looking at family history can give clues as to whether your child is at riskas to whether your child is at risk

Page 94: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

94

Evidence of Harm – Evidence of Harm – IntroductionIntroduction

First Words in Book:First Words in Book:

““Does mercury in vaccines cause autism Does mercury in vaccines cause autism in children? A definitive answer has in children? A definitive answer has proven elusive, and it remains so to this proven elusive, and it remains so to this day.”day.”

““No one can say with certainty that No one can say with certainty that thimerosal helped fuel the explosion in thimerosal helped fuel the explosion in cases of autism, attention deficit cases of autism, attention deficit disorder, speech delay and other disorder, speech delay and other disorders over the past decade.” disorders over the past decade.”

Page 95: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

95

EOH – IntroductionEOH – Introduction““Several potential culprits beside thimerosal have Several potential culprits beside thimerosal have been mentioned, though there is no hard evidence been mentioned, though there is no hard evidence to link any of them to autism. Possible to link any of them to autism. Possible environmental “triggers” include: mercury in fish, environmental “triggers” include: mercury in fish, pesticides, PCB’s, flame retardants, jet fuel, live pesticides, PCB’s, flame retardants, jet fuel, live viruses in vaccines or some as-yet unidentified viruses in vaccines or some as-yet unidentified virus, and even rampant cell phone use. It is virus, and even rampant cell phone use. It is plausible that any combination of the above, with plausible that any combination of the above, with or without thimerosal exposure added into the or without thimerosal exposure added into the mix, might cause harm to some fetuses and infant mix, might cause harm to some fetuses and infant children.”children.”

““At the very least, the thimerosal debate has At the very least, the thimerosal debate has compelled the scientific community, however compelled the scientific community, however reluctantly, to consider an environmental reluctantly, to consider an environmental component to the disorder, rather than looking component to the disorder, rather than looking for a purely genetic explanation.”for a purely genetic explanation.”

Page 96: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

96

EOH IntroductionEOH Introduction

““Some parents, fearing harmful effects, Some parents, fearing harmful effects, have been tempted not to vaccinate their have been tempted not to vaccinate their children. Most people would agree that children. Most people would agree that this is foolhardy and dangerous. Few of us this is foolhardy and dangerous. Few of us are old enough to remember the great are old enough to remember the great epidemics of influenza, pertussis, smallpox, epidemics of influenza, pertussis, smallpox, polio, diphtheria and measles that once polio, diphtheria and measles that once swept entire populations - until the advent swept entire populations - until the advent of vaccines reduced those maladies to of vaccines reduced those maladies to abstract, unthreatening concepts, at least abstract, unthreatening concepts, at least in America. These diseases, all of them in America. These diseases, all of them preventable, can kill children. When preventable, can kill children. When vaccination rates fall, disease rates rise.”vaccination rates fall, disease rates rise.”

Page 97: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

97

WHAT ABOUTWHAT ABOUT

CALIFORNIA?CALIFORNIA?

Page 98: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

98

PossiblePossible Confounding Confounding FactorsFactors

Hg in vaccines and Rho-Gam until 2003.Hg in vaccines and Rho-Gam until 2003. Flu shot for infants and pregnant women.Flu shot for infants and pregnant women. Early intervention – More 3-5 y/o counted.Early intervention – More 3-5 y/o counted. Rising aluminum exposures.Rising aluminum exposures. Rising Hg levels in air and soil.Rising Hg levels in air and soil. Immigration from countries that still use Immigration from countries that still use

Hg.Hg. Expanding criteria in 2008?Expanding criteria in 2008?

Page 99: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

99

The flu shot The flu shot maymay matter matter A pregnant woman receives 25mcg, fetus is also A pregnant woman receives 25mcg, fetus is also

exposed. Much is absorbed by fetal brain stem in exposed. Much is absorbed by fetal brain stem in rats. Human maternal/cord blood ratio is 1:2).rats. Human maternal/cord blood ratio is 1:2).

1lb fetus exposed to 25mcg is 500 times over EPA 1lb fetus exposed to 25mcg is 500 times over EPA limit. limit.

At 6 months, a 7kg baby receives 12.5mcg – or 17 At 6 months, a 7kg baby receives 12.5mcg – or 17 times over limit. At 7 months, baby receives 12.5mcg.times over limit. At 7 months, baby receives 12.5mcg.

At 18 months, a 10kg infant receives 25mcg – or 25 At 18 months, a 10kg infant receives 25mcg – or 25 times overtimes over

Other shots contain 5+ mcg in residual Hg.Other shots contain 5+ mcg in residual Hg.

Total by 18 mos: Total by 18 mos: 80 mcg 80 mcg UK exposure until 2004: UK exposure until 2004: 75 75 mcg mcg

Page 100: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

100

California autism: increase California autism: increase in DDS cases by ethnic in DDS cases by ethnic

group: group: 2003-20072003-2007

30

40

50

60

70

80

90

"Other"

White

Black

AVERAGE

Asian

Filipino

Hispanic

Page 101: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

101

Montreal School Boards: PDD Highest in English Speaking

(Immigrant) District

Page 102: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

102

PDD rates in Lester B. PDD rates in Lester B. Pearson School Board Pearson School Board

(LBPSB) Montreal(LBPSB) Montreal

Page 103: 1 THE VACCINE-AUTISM DEBATE:NEWDEVELOPMENTS FROM SCIENCE AND POLICY Presentation by David Kirby NYU Law School, New York City June 26th, 2008.

103

-June 6, 2007- -June 6, 2007- Canadian Broadcasting Canadian Broadcasting

NewsNews

““Autism rates Autism rates higherhigher in immigrant families”in immigrant families” “ “Health-care specialists in Montreal Health-care specialists in Montreal

are trying to understand why such a are trying to understand why such a high number of autistic children high number of autistic children come from immigrant families, a come from immigrant families, a phenomenon seen in major cities phenomenon seen in major cities across North America.”across North America.”